Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Analytical Chemistry >  Standard >  Pharmaceutical Impurity Reference Standards >  EveroliMus-d4

EveroliMus-d4

Basic information Safety Supplier Related

EveroliMus-d4 Basic information

Product Name:
EveroliMus-d4
Synonyms:
  • EveroliMus-d4 (~90%)
  • Everolimus Impurity 24(Everolimus-d4)
  • EVEROLIMUS (2-HYDROXYETHYL-D4, 98%)
  • Everolimus-d4
  • Everolimus D4Q: What is Everolimus D4 Q: What is the CAS Number of Everolimus D4 Q: What is the storage condition of Everolimus D4 Q: What are the applications of Everolimus D4
  • Everolimus-d4 (Everolimus Impurity)
CAS:
1338452-54-2
MF:
C53H79D4NO14
MW:
962.249067112
Mol File:
1338452-54-2.mol
More
Less

EveroliMus-d4 Chemical Properties

storage temp. 
Store at 4°C
solubility 
Chloroform: Soluble,Methanol: Soluble
form 
A solid
Stability:
Hygroscopic
More
Less

EveroliMus-d4 Usage And Synthesis

Description

Everolimus-d4 is intended for use as an internal standard for the quantification of everolimus by GC- or LC-MS. Everolimus is a hydroxyethyl ether form of rapamycin that inhibits mTOR signaling through both mTORC1 and mTORC2 when added to cells at 20 nM. It is orally available and shows improved pharmacokinetics and pharmacodynamics over rapamycin. Through its inhibition of mTOR, everolimus inhibits cell proliferation, metabolism, and angiogenesis in certain types of cancer. It also acts as an immunosuppressive agent in the context of organ transplantation.

Uses

Macrolide immunosuppressant; derivative of Rapamycin. Inhibits cytokine-mediated lymphocyte proliferation.

General Description

A stable-labeled internal standard for the immunosuppressant Everolimus, marketed as Zortress? and Certican for use in organ transplantation and Afinitor? for treatment of kidney and pancreatic cancers. Clinical laboratories quantitate everolimus levels in patient whole blood samples using LC-MS/MS. While many everolimus LC-MS/MS methods use 32-desmethoxyrapamycin or ascomycin as an internal standard, higher levels of variability / lower levels of reproducibility may occur in the analysis along with the potential for interferences. Use of a stable-labeled analog of everolimus is the best choice to minimize variability or mitigate any potential interference in LC-MS/MS analysis.

EveroliMus-d4Supplier

Chemsky(shanghai)International Co.,Ltd.
Tel
021-50135380
Email
shchemsky@sina.com
Shanghai Aladdin Bio-Chem Technology Co.,LTD
Tel
400-6206333 18521732826;
Email
market@aladdin-e.com
Cato Research Chemicals Inc.
Tel
020-81960175
Email
min.he@cato-chem.com
Artis Biotech Co. Ltd.
Tel
19138486554 18582380095
Email
sales@artisbio.com
Nanjing Haolv Biotechnology Co.,Ltd
Tel
025-84622273 02584622273;
Email
kexin.zhou@haolvbiotech.com